Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma

�irino�lu Demiriz, It�r; Tekg�nd�z, Emre; Civriz Bozda�, Sinem; Altunta�, Fevzi

Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma [Turk J Hematol]

Turk J Hematol. 2014; 31(1): 92-94 | DOI: 10.4274/Tjh.2013.0180

Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma

It�r �irino�lu Demiriz¹, Emre Tekg�nd�z¹, Sinem Civriz Bozda�¹, Fevzi Altunta�²
¹Ankara Oncology Hospital, Department Of Hematology And Stem Cell Transplantation Unit, Ankara, Turkey
²Ankara Oncology Education And Research Hospital, Ankara, Turkey

Yayg�n B�y�k B h�creli Lenfoma Tedavisi Sonras� Sekonder Malignite Olarak Kronik Myeloid L�semi

It�r �irino�lu Demiriz, Emre Tekg�nd�z, Sinem Civriz Bozda�, Fevzi Altunta�. Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma. Turk J Hematol. 2014; 31(1): 92-94

Corresponding Author: It�r �irino�lu Demiriz, T�rkiye

TOOLS

Full Text PDF

Download citation

RIS

EndNote

BibTex

Medlars

Procite

Reference Manager

Share with email

Send email to author

Similar articles

PubMed

Google Scholar

In authors and institutes

In titles and abstracts

In keywords

In all


	E-ISSN: 1308-5263
Archive Most Accessed Articles Most Cited Articles Aims and Scope Instructions For Authors Editorial Board Advisory Board Manuscript Submission Why to Submit Search Contact